Готові списки джерел за темами / Hemostasis

Добірка наукової літератури з теми "Hemostasis"

Автор: Grafiati
Опубліковано: 4 червня 2021
Оновлено: 10 березня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Hemostasis".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій
  6. Звіти організацій

Статті в журналах з теми "Hemostasis":

1

Rathod, Dr Rohit Narendra. "Hemostasis in the Surgical Field." EAS Journal of Medicine and Surgery 4, no. 10 (November 16, 2022): 211–14. http://dx.doi.org/10.36349/easjms.2022.v04i10.003.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Hemostatic mechanisms are an integral a part of the human physiology. Traditionally divided into intrinsic and extrinsic arms, the coagulation cascade converges, through the interactions of the many various factors, at a standard element—thrombin. As a consequence, variety of various agents is developed to supplement this common, critical step to assist surgical hemostasis. Intraoperative interventions most ordinarily include sutures and heat-generating cautery devices; however, these methods are sometimes insufficient or inappropriate for a selected procedure or anatomic location, resulting in the event of other adjunctive therapies, including topical hemostats. Topical hemostatic agents generally act as active, passive, and combinations therapies, counting on their individual composition and mode of action. We offer a quick review of the traditional coagulation cascade, including critical points, followed by a discussion of surgical strategies and adjuctive therapies want to achieve surgical hemostasis and concluding with a discussion of topical thrombins.
2

Romantsov, Mikhail N., Eugene F. Cherednikov, Aleksandr Anatolevich Glukhov, and Constantine O. Fursov. "New technologies of endoscopic hemostasis in a treatment protocol of patients with gastroduodenal ulcer bleeding." Vestnik of Experimental and Clinical Surgery 11, no. 1 (April 8, 2018): 16–23. http://dx.doi.org/10.18499/2070-478x-2018-11-1-16-23.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Relevance of research. Acute gastroduodenal bleeding is remaining a difficult and largely unsolved problem up to day. The fundamental importance in treating this category of patients is an endoscopic hemostasis. The decisive point in this problem is the most stable hemostasis and preventing a recurrence of a hemorrhage. In this regard, the search of new solutions and the development of known methods of treatment of the gastroduodenal ulcer bleeding is an important issue. Aim of research. To evaluate the effectiveness of the treatment protocol of patients with the gastroduodenal ulcer bleeding by applying combined endoscopic insufflations of hemostatic agents and a diovin as an integral part of a complex therapy. Materials and methods. The research is based on results of treatment of the patients with the gastroduodenal ulcer bleeding being in a medical setting at the departments of surgery at Voronezh city clinical emergency hospital №1. During the treatment of the main group (59 patients) there was used an integrated approach with the usage of powdered hemostatic agents of gelplastan and lyophilisate NovoSeven in combination with diovin in the endoscopic treatment of gastroduodenal ulcer bleeding. There were used the traditional well-known methods of the endoscopic hemostasis without the usage of hemostatic agents and absorbent grains in treatment of the control group (56 patients). Results and discussion. The evaluation of results of patients’ treatment with gastroduodenal ulcer bleeding was performed according to the figures of the final hemostasis, the frequency of recurrent bleeding, the prevention of emergency operations, the rates of mortality, the duration of hospitalization. The developed protocol of the patients’ treatment with gastroduodenal ulcer bleeding with the usage of combined the endoscopic insufflation of two hemostatics and diovin makes it possible to achieve the maximum persistent hemostasis at 94.9% of patients, to reduce the risk of recurrent hemorrhages by 2.5 times, to prevent emergency operations and, as a result, to reduce the lethality. Conclusion. The usage of new technologies of endoscopic hemostasis by the hemostatic pneumoinsufflation gelplastan and lyophilisate NovoSeven in combination with diovin in the treatment of patients with gastroduodenal ulcer bleeding allows to reduce the risk of recurrent hemorrhage from 12,5% to 5,01% (by 2,5 times), to prevent emergency operations, to reduce the lethality from 3,65% to 1,7% (by 2,1 times) and to reduce the period of staying in the hospital from 10,2 to 7,4 bed days (p<0.05).
3

Budko, E. V., L. M. Yampolsky, D. A. Chernikova, and A. A. Khabarov. "Comparative evaluation of the effectiveness of a local hemostatic agent modified with a bio-organic composition." CARDIOMETRY, no. 18 (May 18, 2021): 100–112. http://dx.doi.org/10.18137/cardiometry.2021.18.100112.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Constant attention to the study of the experience of using hemostatic products proposed for local bleeding arrest encourages new developments in this field. Modern hemostatics are porous multilayer systems with an inclusion of active coagulants. The results of the assessment of hemostatic activity obtained with the help of clinical and laboratory methods often do not lend themselves to cross-checking and statistical processing, and do not allow us to study objects with different physical and chemical properties. Methods of chemometrics, namely planimetry, allow you to visualize the parameters of sorption and hemocoagulation activity. A comparative planimetric study of commercial local hemostatic agents like Celox powder, sponges and napkins of various companies, zeolite powder, as well as new hemostatic compositions, which were given provisionally label A52 and A58, was carried out. It is shown that the hemostatic composition labeled as A52 leads to the activation of absorbent materials, the formation of a stable volumetric primary and secondary thrombus. A comparative evaluation of the effectiveness of a new hemostatic agent in an acute experiment shows a high expression of hemostasis (the time of primary hemostasis is 15-20 seconds) and no recurrence of bleeding for the studied samples compared to the reference.
4

Wu, Baofeng, Ruixin Zhang, Chendi Liang, Chengjie Zhang, and Gang Qin. "Study on the Safety of the New Radial Artery Hemostasis Device." Journal of Interventional Cardiology 2022 (April 5, 2022): 1–8. http://dx.doi.org/10.1155/2022/2345584.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Objective. At present, the use of particular radial hemostatic devices after coronary angiography (CAG) or percutaneous coronary intervention (PCI) has become the primary method of hemostasis. Most control studies are based on the products already on the market, while only a few studies are on the new hemostatic devices. The aim of this study is to compare a new radial artery hemostasis device which is transformed based on the invention patent (Application number: CN201510275446) with TR Band (Terumo Medical) to evaluate its clinical effects. Methods. In a prospective randomized clinical trial, 60 patients after CAG or PCI were randomly divided into two groups, patients in the trial group (CD group) using a new radial artery hemostasis device to stop bleeding and the control group (TR group) using the TR Band. The method is to collect relevant data of the two groups and compare the differences in hemostasis, local complications, and patient discomfort between the two groups. Results. The hemostatic devices in both groups achieved adequate hemostasis, and there was no failure to stop bleeding. The new radial artery hemostasis device was better than the TR band in pain and swelling ( P < 0.05 ). There were no significant differences in bleeding, hematoma, ecchymosis, skin damage, and local infection between the two groups ( P > 0.05 ). Conclusions. The sample of the new radial artery hemostasis device can stop bleeding effectively at the puncture site after CAG or PCI and is not inferior to the TR Band balloon hemostatic device in safety and is better in comfort.
5

Han, Wenli, and Shige Wang. "Advances in Hemostatic Hydrogels That Can Adhere to Wet Surfaces." Gels 9, no. 1 (December 22, 2022): 2. http://dx.doi.org/10.3390/gels9010002.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Currently, uncontrolled bleeding remains a serious problem in emergency, surgical and battlefield environments. Despite the specific properties of available hemostatic agents, sealants, and adhesives, effective hemostasis under wet and dynamic conditions remains a challenge. In recent years, polymeric hydrogels with excellent hemostatic properties have received much attention because of their adjustable mechanical properties, high porosity, and biocompatibility. In this review, to investigate the role of hydrogels in hemostasis, the mechanisms of hydrogel hemostasis and adhesion are firstly elucidated, the adhesion design strategies of hemostatic hydrogels in wet environments are briefly introduced, and then, based on a comprehensive literature review, the studies and in vivo applications of wet-adhesive hemostatic hydrogels in different environments are summarized, and the improvement directions of such hydrogels in future studies are proposed.
6

Zhuk, S., and V. Vorobey-Vykhivska. "Dynamics of indicators of hemostatic system as prognostic criteria consequences of ART programs." HEALTH OF WOMAN, no. 5(111) (June 20, 2016): 165–70. http://dx.doi.org/10.15574/hw.2016.111.165.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
The article deals with the insurense of haemostatic system on the ART result. The objective: of the study was to establish the relationships between the state of hemostasis in dynamics during the ART program and its results. Patients and methods. The study involved 130 women who underwent infertility treatment through IVF. The dynamics of hemostasis indicators for ART programs is investigated. Results. The trend to a hypercoagulable state in women with failed attempts of IVF is fined. Risk factors ART failure due to hemostasis disorders is established. Conclusions. The evolution of the hemostatic system is an important prognostic criteria on the outcome of ART programs. The lack of signs of a hypercoagulable state can be considered a prerequisite for pregnancy. Dynamic monitoring of hemostasis within ART programs will take timely measures on correction of the hemostatic system and to some extent influence the effects of treatment. Key words: infertility, hemostasis, assisted reproductive technology.
7

Ravn, Hanne. "Hemostasis in Pediatric Cardiac Surgery." Seminars in Thrombosis and Hemostasis 43, no. 07 (June 8, 2017): 682–90. http://dx.doi.org/10.1055/s-0037-1603365.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
AbstractThe majority of children undergoing pediatric cardiac surgery with cardiopulmonary bypass require transfusion of blood products. The management of hemostasis in the pediatric population is challenging, partly due to pronounced alterations in several hemostatic parameters following cardiopulmonary bypass. Despite these marked changes being seen quite often, they are not necessarily an indication for hemostatic interventions. This review summarizes and discusses the available monitoring tests of hemostatic impairment during and following pediatric cardiac surgery. It covers standard laboratory tests, viscoelastic test, evaluation of platelet function, fibrinolysis, and the management of anticoagulation including its reversal. Interpretation of hemostatic measurements is done with due respect to the concept of developmental hemostasis, but also cyanotic heart disease, which are considered by some to be associated with an increased risk of bleeding.
8

Jin, Huiyang, and Zhengke Wang. "Advances in Alkylated Chitosan and Its Applications for Hemostasis." Macromol 2, no. 3 (July 27, 2022): 346–60. http://dx.doi.org/10.3390/macromol2030022.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Chitosan, a natural polysaccharide, has been widely used as a biomaterial, especially for hemostasis. However, hemostatic materials processed from pure chitosan have limited hemostatic effect and are extremely unstable in some cases; chemical modification is therefore needed to improve the hemostatic properties of chitosan. Through chemical reactions with hydroxyl and amino groups in chitosan macromolecules, such as alkylation, carboxylation, quaternization, etc., different groups can be introduced into the repeating units. Moreover, the introduction of different substituents can endow chitosan with more functions. For example, the introduction of long alkyl chains can improve its hydrophobic property, and greatly improve its hemostatic property. However, there is still no review of alkylated chitosan for hemostasis. Therefore, we introduce in detail several methods (direct alkylation, reductive alkylation and acylation reaction) for preparing alkylated chitosan and its applications for hemostasis.
9

Park, Jin-Seok, Byung Wook Bang, Su Jin Hong, Eunhye Lee, Kye Sook Kwon, Hyung Kil Kim, Yong Woon Shin, and Don Haeng Lee. "Efficacy of a novel hemostatic adhesive powder in patients with refractory upper gastrointestinal bleeding: a pilot study." Endoscopy 51, no. 05 (January 10, 2019): 458–62. http://dx.doi.org/10.1055/a-0809-5276.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Abstract Background A new hemostatic adhesive powder (UI-EWD) has been developed to reduce the high re-bleeding rates associated with the currently available hemostatic powders. The current study aimed to assess the efficacy of UI-EWD as a salvage therapy for the treatment of refractory upper gastrointestinal bleeding (UGIB). Methods A total of 17 consecutive patients who had failed to achieve hemostasis with conventional endoscopic procedures and had undergone treatment with UI-EWD for endoscopic hemostasis in refractory UGIB were prospectively enrolled in the study. We evaluated the success rate of initial hemostasis and rate of re-bleeding within 30 days. Results All patients underwent successful UI-EWD application at the bleeding site. Initial hemostasis occurred in 16/17 patients (94 %). Re-bleeding within 30 days occurred in 3/16 patients (19 %) who had achieved initial hemostasis. In the second-look endoscopy after 24 hours, hydrogel from UI-EWD was found attached at the bleeding site in 11/16 patients (69 %). Conclusion UI-EWD has a high success rate for initial hemostasis in refractory UGIB and shows promising results in the prevention of re-bleeding.
10

Dambayev, G. Ts, A. N. Baikov, Ye V. Semichev, M. N. Shpisman, A. N. Aleinik, O. I. Deneko, and P. S. Bushlanov. "The intraoperative methods of hemostasis during liver surgeries." Bulletin of Siberian Medicine 10, no. 4 (August 28, 2011): 89–92. http://dx.doi.org/10.20538/1682-0363-2011-4-89-92.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
This article deals with a short analysis of intraoperative hemostasis in parenchymatous organs by the example of liver. A brief historical survey is given. The hemostatic sutures developed by different formers and the defects of hemostatic sutures are considered. There are some features of instrumental hemostasis, its advantages and disadvantages. The description of the new developed devices on basis of cold plasma, the hemostatic and antiseptic properties of the devices are presented.
Більше джерел
Також вас можуть зацікавити розширені добірки на тему "Hemostasis" для конкретних типів джерел:
Статті в журналах Дисертації Книги

Дисертації з теми "Hemostasis":

1

Keebaugh, Audrey Elizabeth. "Evaluation of hemostasis in hyperthyroid cats." Thesis, Virginia Tech, 2020. http://hdl.handle.net/10919/99376.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Background: Hyperthyroid cats are predisposed to thrombus formation. The mechanism for thrombogenesis is currently unknown, but could be associated with altered hemostasis as seen in hyperthyroid humans. Objective: The purpose of this study was to evaluate markers of hemostasis in hyperthyroid cats compared to healthy cats, and in hyperthyroid cats before and after treatments with radioactive iodine (RIT). Methods: Twenty-five cats with hyperthyroidism and 13 healthy euthyroid cats > 8 years of age were studied. Prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen, antithrombin (AT), D-dimers, thrombin-antithrombin complexes (TAT), von Willebrand Factor antigen (vWF:Ag), and activity of factors VIII and IX were measured. An echocardiogram was performed in all cats and healthy cats with abnormal echocardiograms were excluded. Measurements of hemostasis were evaluated again in 7 cats > 6 months after RIT and deemed to have restored euthyroid status. Results: There is a significant likelihood of being in hypercoagulable state based on hyperthyroid state (P = 0.019) and serum T4 level is significantly associated with predicating hypercoagulability (P = 0.043). Hyperthyroidism is associated with significantly higher median fibrinogen concentration (P < 0.0001), higher median AT activity (P < 0.0001), and higher median vWF:Ag level (P = 0.01) with all values decreasing significantly post-RIT. Fibrinogen and AT had a strong positive correlation with serum T4 value (r = 0.79; 95% CI 0.63 - 0.89 and r = 0.70; 95% CI 0.50 - 0.84, respectively). Presence of an abnormal echocardiogram in hyperthyroid cats was associated with a significantly higher median fibrinogen concentration (P = 0.03). Echocardiographic status did not have a significant impact on the remaining hemostatic markers in hyperthyroid cats. Conclusions: These results provide evidence of altered hemostasis and hypercoagulability in hyperthyroid cats that do not appear to be solely attributed to cardiac abnormalities. These differences of altered hemostasis resolved after radioiodine therapy, but further studies are warranted to determine if hypercoagulable state resolves.
Master of Science
In feline hyperthyroidism, there is a predisposition for thrombus formation. An alteration of hemostasis has been documented in hyperthyroid humans, but despite reports of thrombus formation in hyperthyroid cats, the underlying mechanism is currently unknown. Hyperthyroidism can lead to cardiac abnormalities that could possibly contribute thrombus formation, although thrombus formation has occurred in hyperthyroid cats without detected abnormalities. The goal of this study was to evaluate markers of hemostasis in hyperthyroid cats presenting for radioiodine therapy to evaluate for presence of hypercoagulability. Twenty-five hyperthyroid cats were evaluated with hemostasis panels and echocardiograms. The results were compared to a group of 13 healthy cats. Markers of hemostasis and echocardiograms in 7 hyperthyroid cats were also compared to results 6 months or greater post-radioiodine therapy. There was evidence of altered hemostasis and hypercoagulability in hyperthyroid cats. The alterations noted resolved after radioiodine therapy and do not appear to be solely attributed to cardiac abnormalities seen in hyperthyroid cats.
2

Hormiga, Hernando Gonzalez [UNESP]. "Aplicação de diferentes pinças hemostáticas em veias de equinos: estudo morfológico." Universidade Estadual Paulista (UNESP), 2016. http://hdl.handle.net/11449/144581.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Submitted by HERNANDO EMILIO GONZÁLEZ HORMIGA null (nanoarts@hotmail.com) on 2016-11-02T17:59:46Z No. of bitstreams: 1 Tese.pdf: 3610727 bytes, checksum: ae874ed160c53f81a6efc6c833a53bdc (MD5)
Approved for entry into archive by Felipe Augusto Arakaki (arakaki@reitoria.unesp.br) on 2016-11-10T12:30:07Z (GMT) No. of bitstreams: 1 hormiga_heg_me_bit.pdf: 3610727 bytes, checksum: ae874ed160c53f81a6efc6c833a53bdc (MD5)
Made available in DSpace on 2016-11-10T12:30:07Z (GMT). No. of bitstreams: 1 hormiga_heg_me_bit.pdf: 3610727 bytes, checksum: ae874ed160c53f81a6efc6c833a53bdc (MD5) Previous issue date: 2016-10-27
Foi realizada a avaliação morfológica e morfométrica da veia cefálica submetida à pinçamento de cinco equinos hígidos. Foram testadas as pinças hemostáticas: Diffenbach bulldog, De Bakey bulldog, Rochester reta e De Bakey com cremalheira. Após 15 minutos da aplicação das referidas pinças, foi realizada a flebectomia parcial e coletadas as amostras referentes a cada segmento do vaso pinçado e do segmento controle sem pinçamento. Das peças procedeu-se as preparações histológicas dos segmentos da veia nas colorações de Hematoxilina-Eosina e Tricrômio de Masson, os cortes histológicos foram avaliados por microscopia óptica. Foi realizada análise morfológica das veias, de forma qualitativa, utilizando para isto uma escala de avaliação de lesões vasculares após pinçamento; a avaliação morfométrica, quantificando em micrometros o achatamento produzido pelas pinças nas diferentes camadas vasculares. Em ambos os estudos, morfológico e morfométrico, as pinças com serrilhamento transversal e fechamento tipo cremalheira causaram as maiores alterações, observou se marcada vacuolização das células musculares e desarranjo na túnica media com perda marcada das células endoteliais da túnica intima do vaso estudado.
Morphometric and morphologic evaluation of the cephalic vein of five healthy horses submitted to clamping was done. Hemostatic clamps tested were Dieffenbach bulldog, De Bakey bulldog, Rochester straight and De Bakey with ratchets. 15 minutes after mentioned clamps were applied partial phlebotomy was performed and histologic sections of the veins were prepared and stained with Hematoxylin-Eosin and Masson Trichrome, after the stained preparations were evaluated by light microscopy. A qualitative morphological analysis of the veins was performed using a rating scale of vascular lesions after clamping; the morphometric evaluation consisted in quantifying in micrometers the flattening produced by the hemostatic clamps in the different vascular beds. In both studies, morphologic and morphometric, hemostats with transverse serration and ratcheted mechanism caused major changes, pronounced vacuolization of the muscle cells, derangement of the medium tunic and marked loss of endothelial cells of the intima tunic was observed in the vessel studied.
3

Gonçalves, Daniele Silvano. "Avaliação das alterações hemorrágicas e tromboembólicas em cães com doença renal crônica." Botucatu, 2016. http://hdl.handle.net/11449/134372.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Orientador: Regina Kiomi Takahira
Resumo: A doença renal crônica (DRC) acomete principalmente cães idosos e tem como característica principal a perda irreversível da função renal. A DRC em cães promove alterações metabólicas graves, caracterizadas frequentemente pela azotemia, hipoalbuminemia e anemia não regenerativa. Tanto a azotemia quanto a uremia predispõem a alterações hemostáticas que podem levar a quadros hemorrágicos. Além das disfunções plaquetárias, deficiência de anticoagulantes naturais e redução da fibrinólise são fatores que predispõem ao tromboembolismo. Este trabalho tem como objetivo avaliar as possíveis tendências hemorrágicas ou trombóticas em cães com DRC. Foram selecionados 20 cães saudáveis (grupo controle) com exames dentro da normalidade e 17 cães com DRC em estágios III ou IV classificados segundo a IRIS e a relação proteína/creatirina urinária maior que um (grupo DRC). As amostras de sangue para a realização da tromboelastometria (TEM), agregação plaquetária, tempo de protrombina (TP), tempo de tromboplastina parcial ativada (TTPA) e concentração de fibrinogênio foram colhidas em momento único para ambos os grupos após os critérios de inclusão serem confirmados. A análise estatística foi realizada de acordo com a distribuição das variáveis, ao nível de 5% de significância. No presente estudo foi possível observar um estado de hipercoagulabilidade sanguínea nos cães com DRC. Na TEM com o ativador de via extrínseca, observou-se encurtamento no tempo de coagulação e do tempo de formação do coá... (Resumo completo, clicar acesso eletrônico abaixo)
Abstract: Chronic kidney disease (CKD) affects mostly older dogs and its main characteristic is the irreversible loss of kidney function. CKD in dogs promotes serious metabolic alterations, often characterized by azotemia, hypoalbuminemia and non-regenerative anemia. Azotemia and uremia predispose the hemostatic abnormalities that can lead to hemorrhagic cases. In addition to platelet dysfunction, deficiency of natural anticoagulants and reduced fibrinolysis are factors that predispose to thromboembolism. This work aims to evaluate the possible bleeding or thrombotic tendencies in dogs with CKD. 20 healthy dogs were selected (control group) with tests within normal limits and 17 dogs with CKD in stages III or IV classified according to IRIS and urine protein to creatinine ratio greater than one (CKD group). Blood samples for the realization of thromboelastometry (TEM), platelet aggregation, prothrombin time (PT), activated partial thromboplastin time (APTT) and fibrinogen concentration were collected at one time for both groups after the inclusion criteria had been confirmed. Statistical analysis performed according to the distribution of the variable at the 5% level of significance. In the present study, we observed a state of hypercoagulable blood in dogs with CKD. In TEM with the extrinsic pathway activator, there was shortening of the clotting time and clot formation time, increasing the alpha angle and the maximum clot firmness, and reducing the maximum lysis in dogs with CKD comp... (Complete abstract click electronic access below)
Mestre
4

Joesph, Wiencek R. "Regulating Hemostasis: The Factor Va Cofactor Effect." Cleveland State University / OhioLINK, 2015. http://rave.ohiolink.edu/etdc/view?acc_num=csu1431514489.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Lindfelt, Jan O. W. "Hepatic nerves in hemostasis and glucose metabolism :." Lund : Dept. of Surgery, Lund University, 1993. http://catalog.hathitrust.org/api/volumes/oclc/39654187.html.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Peterle, Daniele. "Molecular Mechanism in the Alteration of Hemostasis." Doctoral thesis, Università degli studi di Padova, 2018. http://hdl.handle.net/11577/3426350.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Hemostasis is a finely tuned physiological process that, through the concerted action of several blood cells and proteins, maintains the integrity of the vascular system. This stepwise process begins after a vessel wall injury and includes: an initial vasospasm, a platelet plug formation (primary hemostasis), an assembly and activation of the coagulation factors that results in fibrin deposition at the site of injury (secondary hemostasis), and a final dissolution of the fibrin clot that restores the blood vessel patency (fibrinolysis) (Chapter 1). Alterations affecting one or more of these delicate processes lead to a large number of pathological manifestations, commonly referred to as cardiovascular diseases (CVD). Nowadays, CVD are the major cause of mortality and morbidity worldwide. Despite the social and economic burden of CVD, the currently available pharmaceutical repertoire is relatively limited to a few classes of molecules (heparins, platelet antiaggregants, vitamin-K antagonists, direct thrombin inhibitors) which, however, display important side effects and need to be employed with careful dose adjustments. These difficulties stem primarily from: i) the intrinsically complex nature of the procoagulant and anticoagulant biochemical mechanisms leading to physiological hemostasis, which renders external intervention very risky and unpredictable; ii) the inadequate knowledge of the biochemical mechanisms linking blood coagulation to other vital physio-pathological processes. The general aim of this Ph.D. project was to investigate some of the molecular mechanisms underlying hemostatic disorders. To address this relevant question, we proceeded by studying selected pathologies for which association with hemostatic complications has either been long-established (i.e., Antiphospholipid Syndrome (APS), infectious diseases) or has just been hypothesized (Parkinson’s disease (PD), Transthyretin-related Amyloidosis (ATTR)), focusing our attention on the physio-pathological proteins involved in the onset of these disorders. In a first stage, our attention was focused on the study of novel interactions between α-thrombin (αT), the key enzyme of the coagulation cascade, with other plasma proteins (i.e., β2-glycoprotein-I, α-synuclein). In a second stage, we investigated an alternative mechanism of activation of prothrombin, the precursor of αT, by a bacterial protease (subtilisin from B. subtilis). Finally, some selected proteases were tested against human transthyretin, whose proteolyzed form is a key factor in the onset of ATTR. In its traditional pathway, blood coagulation culminates with the FXa-mediated conversion of prothrombin zymogen into active αT, through the formation of the prothrombinase complex on the platelet surface. Mature αT is a 36.7 kDa serine protease with a chymotrypsin-like fold. αT plays a pivotal role in blood coagulation, being able to exert both procoagulant (platelets aggregation, fibrin generation) and anticoagulant (protein C activation) functions. The equilibrium between such different activities is regulated by the interaction of αT with other proteins through its active site and two positively charged regions, called exosites (exosite I and exosite II), which flank the catalytic cleft. In addition, αT is a multifunctional protease that, beyond blood coagulation, plays important roles also in other physiological processes such as inflammation, innate immune system, and nervous systems. In Chapter 2 we mapped the interaction between αT and β2-Glycoprotein I (β2GpI). β2GpI is a heavily glycosylated 45 kDa protein that resides in human plasma at a physiological concentration of 4 µM (0.25 mg/ml). Since the early 90's, β2GpI has been identified as the major autoantigen in the antiphospholipid syndrome (APS), a severe autoimmune disease clinically characterized by hemostatic alterations such as venous and arterial thrombosis, fetal loss and thrombocytopenia. Despite its involvement in the pathogenesis of APS, the physiological roles of β2GpI remain unclear and both pro- and anti-coagulant functions have been reported for this protein. In a recent work, we have shown that β2GpI selectively inhibits the procoagulant functions of human α-thrombin (i.e. prolongs fibrin clotting time, tc, and inhibits α-thrombin-induced platelets aggregation) without affecting the unique anticoagulant activity of the protease (i.e. the proteolytic generation of the anticoagulant protein C). Here, combining molecular modeling with biochemical/biophysical techniques, we provided a coherent structural model of αT-β2GpI complex. The model has allowed us to understand at the molecular level our previous in vitro results. In particular, our findings suggested that β2GpI may function as an anticoagulant protein, acting as a scavenger of αT for the binding to GpIbα receptor, thus impairing platelets aggregation while enabling normal cleavage of fibrinogen and protein C. Chapter 3 was dedicated to the role of bacterial proteases in inducing blood coagulation by direct proteolytic activation of prothrombin. This knowledge gap is particularly concerning, as bacterial infections are frequently complicated by severe coagulopathies, and, in about 35% of sepsis cases, by disseminated intravascular coagulopathies (DIC). Here, we show that addition of subtilisin (50 nM–2 µM), a serine protease secreted by the nonpathogenic bacterium Bacillus subtilis, to human plasma induces clotting by proteolytically converting prothrombin into active σPre2, a nicked Pre2 derivative with a single cleaved Ala470–Asn471 bond. Notably, we found that this non-canonical cleavage at Ala470–Asn471 is instrumental for the onset of catalytic activity in σPre2, which was however reduced of about 100-200 fold compared with natural αT. Of note, σPre2 could generate fibrin clots from fibrinogen, either in solution or in blood plasma, and could aggregate human platelets, either isolated or in whole blood. Our findings demonstrate that alternative cleavage of prothrombin by proteases, even by those secreted by non-virulent bacteria such as B. subtilis, can shift the delicate procoagulant-anticoagulant equilibrium toward thrombosis. The study object presented in Chapter 4 is the interplay between αT and α-synuclein (αSyn). αSyn is a small (14.6 kDa) presynaptic protein mainly synthesized in the brain and whose aggregation has been shown to trigger the onset of different neurodegenerative diseases, commonly referred to as synucleinopathies (i.e., Parkinson disease). As for β2GpI, the exact physiological role of αSyn is still elusive. Intriguingly, αSyn is also synthesized by platelets and was found to inhibit the Ca2+-dependent release of procoagulant α-granules after αT stimulation. Moreover, clinical evidences clearly indicate that patients affected by neurodegenerative disorders have lower risks of ischemic attack. The collateral effects of αSyn in the pathogenesis and its localization on platelet surfaces prompted us to investigate a possible role of it in the hemostatic system. Here, we studied the effects of αSyn on fibrin generation and platelet activation. Furthermore, we mapped the interaction sites on αSyn and αT. Briefly, our results indicate that the negatively charged C-terminal tail of αSyn binds to the electropositive exosite-2 of thrombin, thus impairing αT-mediated platelet activation in whole blood. At variance, αSyn does not alter the rate of fibrin generation, resulting only in a minor change in the ensuing fibrin structure. In Chapter 5 we attempted to correlate the onset of systemic transthyretin amyloidosis to an altered activation of blood coagulation. Human transthyretin (hTTR) is an abundant homo-tetrameric plasma protein (0.2 mg/ml) involved in the transport of thyroxine and retinol through the binding to retinol binding protein. Beyond its physiological roles, hTTR is known as an amyloidogenic protein whose aggregation is responsible for several amyloid diseases, including senile systemic amyloidosis (SSA), familial amyloid polyneuropathy (FAP), and familial amyloid cardiomyopathy (FAC). From a mechanistic point of view, the proteolytic cleavage of hTTR represents an important step in fibril formation. In particular, after cleavage around position 50, hTTR C-terminal fragments have been found to aggregate far more efficiently than the full-length hTTR. Nowadays, the protease(s) responsible for this cleavage is yet to be identified although it is predicted to be a serine protease with a trypsin-like fold. Since all coagulation factors are trypsin-like serine proteases, we decided to probe them for the proteolytic cleavage of hTTR. In addition, we also probed some selected bacterial proteases, as well as some digestive apparatus and immune system proteases. hTTR was resistant to all proteases tested except to subtilisin from B. subtilis, which was able to cleave hTTR at pH 7.4, generating in high yields the amyloidogenic fragment hTTR(59-127). Since the hTTR(59-127) fragment was identified in amyloid deposits, these new insights might have relevant implications in hTTR-based amyloidosis.
7

Teixeira, Bruno Costa. "Efeito de diferentes intensidades de exercício aeróbio prévio, sobre a curva lipêmica, inflamação e hemostasia de sujeitos submetidos à refeição hiperlipídica." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2016. http://hdl.handle.net/10183/142537.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Introdução: O consumo habitual de refeições ricas em gordura tem se mostrado indutor de doenças cardiovasculares (DCV), afetando o equilíbrio entre os sistemas de coagulação e fibrinólise e também induzindo o aumento de marcadores inflamatórios. Por outro lado, o exercício físico tem sido indicado como intervenção por atenuar o incremento da inflamação e equilibrar os sistemas hemostáticos em indivíduos que consomem uma refeição hiperlipídica (RH). Objetivo: Verificar o efeito subagudo de duas sessões com intensidades diferentes de exercício aeróbio na curva lipêmica, inflamação, hemostasia em sujeitos jovens saudáveis submetidos à refeição hiperlipídica. Metodologia: Onze sujeitos eutróficos do sexo masculino, fisicamente ativos, com idade média de 23 ± 3 anos participaram do estudo que foi composto por três protocolos com dois dias consecutivos cada. No dia 1 os sujeitos realizavam um dos três protocolos que era realizado de forma randomizada, os protocolos eram divididos em: exercício de baixa intensidade (BI), exercício de moderada intensidade (MI) e repouso (Con). No dia dois 12h após a realização do exercício prévio os sujeitos consumiam uma RH (15% proteínas, 35% carboidratos e 50% lipídeos). Foram realizadas coletas de sangue para analise de triglicerídeos (TG), Colesterol total (CT), lipoproteínas de alta densidade (HDL), lipoproteínas de baixa densidade (HDL) e Glicose, no basal (BS) e a cada hora de 1 à 5h após a RH. As coletas sanguíneas para análise de Ativador de plasminogênio (tPA), Inibidor do ativador de plasminogênio do tipo 1 (PAI-1), Fator de necrose tumoral alfa (TNFα), Interleucina 6 (IL-6) e Interleucina 10 (IL-10) foram realizadas no momento basal, 1h, 3h e 5h após a RH. Resultados: Os protocolos BI e MI apresentaram menor área abaixo da curva (AUC) de TG em relação ao Con (P<0,05). Houve diferença significativa no PAI-1 em relação ao BI quando comparado ao MI e Con e de tPA do protocolo BI em relação ao Con no momento 1h pós refeição (P<0,05). No FVII, os protocolos MI e BI foram significativamente menores que o Con no momento 1h pós RH (p<0,05). Houve diferença significativa em TNFα entre os protocolos MI e Con no momento 1h pós RH (P<0,05) e foram encontradas diferenças em IL-10 nos protocolos MI e Con nos momentos 1h e entre os protocolos MI e BI nos momentos 1h, 3h e 5h pós RH (P<0,05). Houve diferença em IL-6 em todos os momentos de todos os protocolos em relação ao momento basal (BS). Conclusão: A RH aumenta o estado inflamatório e desregula o equilíbrio entre coagulação e fibrinólise, o protocolo BI e MI atenuam a curva de TG em relação ao Con, o protocolo MI melhorou o estado inflamatório diminuindo TNFα e incrementado IL-10 e o protocolo BI melhorou a relação entre coagulação e fibrinólise atenuando a diminuição de tPA e diminuindo o incremento de PAI-1 e ambos os protocolos MI e BI não incrementaram FVII 1h após RH.
Background: Regular consumption of high-fat meals has been considered to play a role in the development of cardiovascular diseases. The increase of postprandial lipemia after a high-fat meal consumption can imbalance the relationship between coagulation and fibrinolysis and, by consequence, enhance an inflammatory response. Conversely, exercise has been considered an important intervention, once it may attenuate inflammatory responses and counterbalance hemostatic systems during the postprandial period. Purpose: Verify the subacute effect of two exercise bouts performed at different intensities on postprandial lipemia, inflammation and hemostasis after the consumption of a high-fat meal. Methods: Eleven healthy and physically active male subjects with average age of 23 ± 3 years completed 2-day trials in three conditions: Control, low-intensity exercise (LI) and moderate-intensity exercise (MI). Subjects performed an exercise bout (LI or MI) or no exercise (Control) on the evening of day 1. On the morning of day 2, a high-fat meal was provided (15 % of protein, 35 % of carbohydrates and 50 % of lipids). Blood was sampled at fasting (0 h) and every hour from 1 to 5 h for triglycerides (TG), total cholesterol, HDL, LDL and glucose. For plasminogen activator inhibitor-1 (PAI-1), plasminogen activator (tPA), tumor necrosis factor-alpha (TNFα), interleukin-6 (IL-6) and interleukin-10 (IL- 10), blood was sampled at 0, 1, 3 and 5 h. Results: TG area under the curve (AUC) was lower in LI and MI than Control (P<0.05). For PAI-1, there was a difference from LI to MI and Control at 1 h (P<0.05). For tPA, there was a difference from LI to Control at 1 h (P<0.05). For FVII the protocols MI and BI there was difference from Con in at 1h. For TNFα, there was a difference from MI to Control at 1 h (P<0.05). IL-10 concentration was different from MI to Control at 1 h and from MI to LI at 1, 3 and 5 h (P<0.05). Fasting IL-6 concentrations were different between all conditions (P<0.05). Conclusion: The consumption of a high-fat meal increases the inflammatory process and deregulates the balance between coagulation and fibrinolysis. Exercise, independent of the intensity, can reduce TG AUC compared to Control. MI can reduce TNFα and increases IL-10, while LI regulates coagulation and fibrinolysis balance, which can be explained by the increase in tPA and increase in PAI-1.
8

Boknäs, Niklas. "Studies on interfaces between primary and secondary hemostasis." Doctoral thesis, Linköpings universitet, Avdelningen för mikrobiologi och molekylär medicin, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-132413.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Our conceptual understanding of hemostasis is still heavily influenced by outdated experimental models wherein the hemostatic activity of platelets and coagulation factors are understood and studied in isolation. Although perhaps convenient for researchers and clinicians, this reductionist view is negated by an ever increasing body of evidence pointing towards an intimate relationship between the two phases of hemostasis, marked by strong interdependence. In this thesis, I have focused on factual and proposed interfaces between primary and secondary hemostasis, and on how these interfaces can be studied. In my first project, we zoomed in on the mechanisms behind the well-known phenomenon of thrombin-induced platelet activation, an important event linking secondary to primary hemostasis. In our study, we examined how thrombin makes use of certain domains for high-affinity binding to substrates, called exosite I and II, to activate platelets via PAR4. We show that thrombin-induced platelet activation via PAR4 is critically dependent on exosite II, and that blockage of exosite II with different substances virtually eliminates PAR4 activation. Apart from providing new insights into the mechanisms by which thrombin activates PAR4, these results expand our knowledge of the antithrombotic actions of various endogenous proteins such as members of the serpin superfamily, which inhibit interactions with exosite II. Additionally, we show that inhibition of exosite II could be a feasible pharmacological strategy for achieving selective blockade of PAR4. In my second project, we examined the controversial issue of whether platelets can initiate the coagulation cascade by means of contact activation, a hypothesis which, if true, could provide a direct link between primary and secondary hemostasis. In contrast to previous results, our findings falsify this hypothesis, and show that some of the erroneous conclusions drawn from earlier studies can be explained by inappropriate experimental models unsuitable for the study of plateletcoagulation interfaces. My third project comprised an assessment of the methodological difficulties encountered when trying to measure the ability of platelets to initiate secondary hemostasis by the release of microparticles expressing tissue factor. Our study shows that the functional assays available for this purpose are highly susceptible to error caused by artificial contact activation. These results could help to improve the methodology of future research and thus pave the way for new insights into the roles of tissue factor-bearing microparticles in the pathophysiology of various thrombotic disorders. From a personal perspective, my PhD project has been a fascinating scientific odyssey into the largely unexplored interfaces between primary and secondary hemostasis. Looking forward, my ambition is to continue our work exploring platelet-coagulation interactions and to translate these insights into clinically meaningful information, which may someday improve the treatment of patients with bleeding and/or thrombosis.
9

Kurdi, Mohamad. "Study of the clearance of proteins of hemostasis." Paris 7, 2011. http://www.theses.fr/2012PA077071.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Le but de ce projet de thèse a été d'étudier la clairance de glycoprotéines jouant un rôle clé dans l'hémostase, le facteur X (FX) et le couple facteur Willebrand (FW)/facteur VIII (FVIII) qui circule dans le plasma sous forme de complexe non covalent. Dans la première partie de nos travaux, nous avons étudié l'implication des N-glycosylations du FX sur sa clairance. Il avait été préalablement établi par l'équipe que ces N-glycans influençaient la cinétique d'élimination du FX. Nous avons désormais établi qu'ils influencent également la biodistribution et les interactions cellulaires de la protéine. Ainsi, comparé au FX, un variant de FX N-déglycosylé interagit avec des types cellulaires différents au niveau du foie qui est l'organe principal de biodistribution de cette protéine. Le FX N-déglycosylé se lie et est dégradé par les hépatocytes. Quant au FX, il se lie aux cellules de Kupffer. Cette liaison du FX aux cellules de Kupffer semble d'ailleurs faire partie d'un mécanisme original protégeant le FX d'une clairance accélérée. Le FW et le FVIII sont des glycoprotéines dont les glycans sont fortement sialylés. Dans la deuxième partie de cette thèse, le rôle du récepteur Sialic acid-binding Ig-like lectin 5 (Siglec-5) dans la clairance du complexe FVIII/FW a été étudié. Siglec-5 est un récepteur présent à la surface des macrophages, type cellulaire dominant dans la clairance du complexe FVIII/FW. Nous avons montré que le FVIII et le FW peuvent se lier au Siglec-5. De plus, une surexpression de Siglec-5 in vivo est associée à une diminution des taux endogènes de FW et de FVIII. Ces résultats suggèrent que Siglec-5 joue un rôle dans le catabolisme du complexe FVIII/FW
The main objective of this thesis was to study the clearance mechanisms of glycoproteins playing a key role in the hemostatic process, factor X (FX) and the factor VIII (FVIII)/von Willebrand factor (VWF) couple which circulates in plasma in a tight non-covalent complex. In the first part of our work, we have studied the involvement of FX N-glycosylations on its clearance. It had been previously established by the team that these N-glycans were important for the long half-life of FX. We have now extended these data by showing that N-glycosylations also influence organ biodistribution and cellular interactions of the protein. Indeed, as compared to FX, a N-deglycosylated FX variant interacts with different cell types in the liver which is the main target organ for FX biodistribution. N-deglycosylated FX binds to and is degraded by hepatocytes. Conversely, FX binds to Kupffer cells. The binding of FX to Kupffer cells appears to be part of an original mechanism protecting FX from an accelerated clearance. Both VWF and FVIII are glycoproteins whose glycans are capped with sialic acids. In the second part of this thesis, we have studied the role of a receptor, Sialic acid-binding Ig-like lectin 5 (Siglec-5), in the clearance of the FVIII/VWF complex. Siglec-5 is expressed on the surface of macrophages, a cell type that is dominant in the clearance of this complex. Our results showed that FVIII and FW are ligands for Siglec-5. Furthermore, overexpression of Siglec-5 in vivo is associated with decreased endogenous levels of the two glycoproteins. These results suggest that Siglec-5 can play a role in the catabolism of the FVIII/FW complex
10

Shoffstall, Andrew J. "The Use of Synthetic Platelets to Augment Hemostasis." Case Western Reserve University School of Graduate Studies / OhioLINK, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=case1363775111.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Hemostasis":

1

F, Feldman Bernard, ed. Hemostasis. Philadelphia: W.B. Saunders, 1988.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Bennett, Sterling T., Christopher M. Lehman, and George M. Rodgers. Laboratory Hemostasis. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-08924-9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Marcucci, Carlo Enrique, and Patrick Schoettker, eds. Perioperative Hemostasis. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-55004-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Thompson, Catherine, and Robert C. Blaylock, eds. Laboratory Hemostasis. Boston, MA: Springer US, 2007. http://dx.doi.org/10.1007/0-387-36840-x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Saba, Hussain I., and Harold R. Roberts, eds. Hemostasis and Thrombosis. Oxford, UK: John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118833391.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Kini, R. Manjunatha, Kenneth J. Clemetson, Francis S. Markland, Mary Ann McLane, and Takashi Morita, eds. Toxins and Hemostasis. Dordrecht: Springer Netherlands, 2011. http://dx.doi.org/10.1007/978-90-481-9295-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

DeLoughery, Thomas G., ed. Hemostasis and Thrombosis. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-09312-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Takada, A., and A. Z. Budzynski, eds. Hemostasis and Circulation. Tokyo: Springer Japan, 1992. http://dx.doi.org/10.1007/978-4-431-66925-8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Szumita, Richard P., and Paul M. Szumita, eds. Hemostasis in Dentistry. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-71240-6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Ma, Alice D., Harold R. Roberts, and Miguel A. Escobar. Hemophilia and Hemostasis. Oxford: John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781118439289.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Hemostasis":

1

Sobanko, Joseph F. "Hemostasis." In Safety in Office-Based Dermatologic Surgery, 63–75. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13347-8_8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Bloch, Michael H., Michael H. Bloch, Mark A. Geyer, David C. S. Roberts, Eileen M. Joyce, Jonathan P. Roiser, John H. Halpern, et al. "Hemostasis." In Encyclopedia of Psychopharmacology, 578. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_802.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Orbell, Sheina, Havah Schneider, Sabrina Esbitt, Jeffrey S. Gonzalez, Jeffrey S. Gonzalez, Erica Shreck, Abigail Batchelder, et al. "Hemostasis." In Encyclopedia of Behavioral Medicine, 957. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_100792.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Saliba, Zakhia, Ramy C. Charbel, and Tarek Smayra. "Hemostasis." In Atlas of Cardiac Catheterization for Congenital Heart Disease, 53–61. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-72443-0_6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

MacNeill, Amy L. "Hemostasis." In Clinical Pathology and Laboratory Techniques for Veterinary Technicians, 75–94. Chichester, UK: John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119421351.ch3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Saliba, Zakhia S., Sami G. Slaba, and Elie B. Sawan. "Hemostasis." In Cardiac Catheterization for Congenital Heart Disease, 181–91. Milano: Springer Milan, 2014. http://dx.doi.org/10.1007/978-88-470-5681-7_13.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Raimondi, Anthony J. "Hemostasis." In Pediatric Neurosurgery, 175–96. New York, NY: Springer New York, 1987. http://dx.doi.org/10.1007/978-1-4757-4202-2_9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Sainburg, Robert L., Andrew L. Clark, George E. Billman, Zachary J. Schlader, Toby Mündel, Kevin Milne, Earl G. Noble, et al. "Hemostasis." In Encyclopedia of Exercise Medicine in Health and Disease, 405–8. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-540-29807-6_47.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Saliba, Zakhia, and Ramy C. Charbel. "Hemostasis." In Cardiac Catheterization for Congenital Heart Disease, 211–21. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-69856-0_15.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Hoballah, Jamal J., and Rakan Nasser Eldine. "Hemostasis." In Vascular Reconstructions, 139–52. New York, NY: Springer New York, 2021. http://dx.doi.org/10.1007/978-1-0716-1089-3_5.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Hemostasis":

1

Crum, Lawrence. "Acoustic hemostasis." In 15th international symposium on nonlinear acoustics: Nonlinear acoustics at the turn of the millennium. AIP, 2000. http://dx.doi.org/10.1063/1.1309175.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Grabowski, F. E. "RHEOLOGY AND PRIMARY HEMOSTASIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643986.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Overview The adhesion-aggregation of platelets to a site of vessel wall injury is a quintessential blood flow phenomenon. Firstly, platelets are driven to the vicinity of the vessel wall by a form of convective diffusion in which red cells both mechanically augment the effective platelet diffusivity (Turitto et al., Ind. Eng. Chem. Fund. 11:216-223, 1972; Grabowski et al., Ind. Eng. Chem. Fund. 11:224-232, 1972) and enhance the near-wall piatelet concentration (Ti11es and Eckstein, Microvasc Res., In press, 1987). Secondly, red cells subjected to physiologic shear forces are capable of secreting sufficient adenine nucleotides to induce primary platelet aggregation without themselves undergoing frank lysis (Reimers et al, Blood 64:1200-1206, 1984). This "humoral" effect of erythrocytes is likely to contribute to primary hemostasis in a shear stress-dependent manner. Thirdly, endothelial cells are able to modulate platelet aggregation at a site of vessel injury by producing prostacyclin (and perhaps other antithrombotic substances) in a manner which increases with vessel shear rate (Grabowski et al, Blood 62:301a, 1983); production for a large range of arterial shear rates appears to be limited by plasma-borne substrate (arachidonate). This manner of production ensures a concentration of prostacyclin in the near-wall region which remains relatively independent of shear rate.Imaging primary hemostasis. In our work, epi-fluorescence videomicroscopy has allowed real time imaging of platelet adhesion-aggregation to a simulated vessel wall injury. The injury model is an endothelial cell monolayer (ECM) across which, prior to ECM exposure to flowing blood, a 6-0 sterile suture is drawn in a direction transverse to flow. Microinjuries result which measure 70 ± 15μm (Mean ± SD) in width. The fluorescent label is the TAB murine monoclonal antibody (courtesy of Dr. R.P. McEver) directed against human platelet GPIIB, together with a fluorescein-conjugated goat F(ab')2 against murine inmunoglobulin. The injured ECM's, grown to confluence on rectangular cover glasses precoated with microfibrillar collagen, comprise one wall of a flow chamber mounted on a vertical microscope stage. On microinjury sites and at shear rates of 100 to 700 sec-1, computer-enhanced video images show adherence, remodelling and growth of chains of platelet aggregates. Aligned with the flow direction, these chains have a spacing of approximately 30)im, a length similar to the average endothelial cell diameter. One may speculate that such chains provide a scaffold for wound healing insofar as they are likely rich in agents chemotactic for leukocytes and in platelet-derived growth factor.Modulatory role of endothelium. When the ECM's are pre treated with 1.0 mM FC lysine acetyl sal icy late (LA), aggregate length increases (P<0.001) up totwo-fold, outflow levels by RIA of serum thromboxane B2 increase (8 of 8 paired runs), and outflow levels of prostacyclin by RIA for 6-Keto PGFiot decrease (5 of 7 paired runs). The Table gives data for one of four similar experiments at 270 sec-1 and following five minutes of flow. These data imply that products of ECM which are inhibitable by aspirin modulate local adhesion-aggregation; their inhibition, as by vasculitis or drugs, may give rise to thrombotic states.Bleeding disorders. Aggregate length is reduced in von Willebrand's disease (4 patients), Hermansky-Pudlak syndrome (2 patients), and after 300 mg oral aspirin (Tablet 4 donors). The reduction in the first two, however, is greater (P<0.01) than that for oral aspirin. With oral aspirin, further, there is a paradoxic increase in the percent platelet coverage of the injury area. Summary. Rheology has profound effects on the rate, structure, and modulation of primary hemostasis. Many of these effects can be studied via real-time, epi-fluorescence videomicroscopy of platelet adhesion-aggregation to a site of injury to an endothelial cell monolayer exposed to flowing blood. The model described has application to the study of thrombotic and hemostatic disorders and unstable angina.
3

Brittain, S. B., J. L. Hajjar, and S. S. Nidadavolu. "In-vitro hemostasis test platform." In 2011 37th Annual Northeast Bioengineering Conference (NEBEC). IEEE, 2011. http://dx.doi.org/10.1109/nebc.2011.5778553.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Berdysh, D. S., S. G. Pavlenko, and Evgeny Marchenko. "COMPARATIVE CHARACTERISTICS OF KIDNEY WOUND HEMOSTASIS WHEN USING PECTINS IN AN EXPERIMENT." In NOVEL TECHNOLOGIES IN MEDICINE, BIOLOGY, PHARMACOLOGY AND ECOLOGY. Institute of information technology, 2022. http://dx.doi.org/10.47501/978-5-6044060-2-1.142-145.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
The article presents data on the hemostatic properties of apple and citrus pectins on the model of an incised wound of the lower pole of the kidney (parenchymal bleeding). The time of com-plete hemostasis when using pectins is 10 seconds. The volume of blood loss does not exceed 0.3 mg per organ.
5

Farag, A. M., S. F. Bottoms, E. F. Mammen, M. Hosni, and A. Ali. "EFFECT OF ORAL CONTRACEPTIVES ON HEMOSTASIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644283.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Retrospective statistical epidemiological studies have suggested a possible association between the ingestion of oral contraceptives (OC) and thromboembolic disease. Past analyses of the coagulation system have yielded controversial informationWe studied a cross section of 131 women taking different kinds of OC and 36 controls for changes in hemostasis. No significant differences were noted in the levels of fibrino- peptide A (RIA), platelet factor 4, 8 thromboglobulin (RIA), fibrinogen (Multistat III (MCA), clottable), antithrombin III (MCA, S-2238), α2 antiplasmin (MCA, S-2251), pre-kallikrein (MCA, S-2302) and fibronectin (MCA, immune turbi-dometric). However, plasminogen (MCA, S-2251) and protein C antigen (Laurell) levels were significantly elevated (p < 0.001 and p < 0.01), respectively)Canonical correlation analysis was used to examine correlations between hemostasis parameters measured and clinical risk factors, such as age, parity, weight, smoking, family history for thromboembolic diseases and estrogen-progesterone dose. There was a significantly negative correlation between family history for thromboembolisms and antithrombin III levels (p < 0.01). A positive correlation existed between obesity and fibrinogen and fibronectin levels (p < 0.001 for both). The hemostasis data seem to suggest that OC use does not introduce an imbalance in the hemostasis system which fosters "hypercoagulability", and that, if at all, possibly other risk factors determine the incidence of thromboembolisms in OC users. It is suggested that caution be exercised in the use of OCs in patients with a history of thromboembolic diseases and with obesity
6

Zderic, Vesna. "Thin-Profile Transducers for Intraoperative Hemostasis." In 4TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND. AIP, 2005. http://dx.doi.org/10.1063/1.1901650.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Solovchuk, Maxim, and Wen-Hann Sheu. "Computational model for investigating acoustic hemostasis." In The 2013 International Workshop on Computational Science and Engineering. Trieste, Italy: Sissa Medialab, 2014. http://dx.doi.org/10.22323/1.202.0019.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Sapkota, A. "Metabolome Analysis for New Possible Hemostasis Biomarkers." In 63rd Annual Meeting of the Society of Thrombosis and Haemostasis Research. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1680273.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Saleh, A. A., A. M. Farag, S. F. Bottoms, E. F. Mammen, M. Hosni, and A. Ali. "SELECTED HEMOSTASIS PARAMETERS IN PREGNANCY AND HYPERTENSION." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644284.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Patients with preeclampsia are believed to have a state of compensated DIC, and especially the differential diagnosis between preeclampsia and chronic hypertension with pregnancy can be difficult. Selected hemostasis parameters were analyzed in 50 women with preeclampsia (P), 50 matched normal pregnant women (N), 14 women with known hypertensionand pregnancy (CH) and 13 persons with known chronic hypertension and superimposed preeclampsia (CH + P). None of the patients had clinical evidence of DIC. Platelet counts, mean platelet volume, antithrombin III, α2 antiplasmin and fibrinogen activities and fibronectin were assayed. The following data wereThese data, together with higherlevels of fibrinopeptide A, platelet factor 4, 3 thromboglobulin and D-dimer in the P group suggests increased intravascular coagulation in preeclampsia. Fibronectin levels were markedly elevated only in the patient groups with preeclampsia. Discriminant function analysis of FN values between the groups revealed a78% diagnostic accuracy for Palone and 74% accuracy for CH + P
10

Belov, V. P., and E. A. Vinokurova. "Perioperative period in the radical treatment of uterine cancer: features of management." In Наука России: Цели и задачи. НИЦ "LJournal", 2021. http://dx.doi.org/10.18411/sr-10-08-2021-06.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Purpose of the study is to characterize the state of coagulation and state of lipid peroxidation and antioxidant potential in cases of women with uterine cancer during surgery, to evaluate the effectiveness of the of antioxidants used in order to correct changes in the hemostatic system. 104 women were examined. Women were separated into 3 groups: healthy, receiving standard therapy and standard therapy + selmevitum. the patients showed a change in hemostasis which was mostly prevented by using additional vitamin and mineral complex – selmevitum before and after operation.

Звіти організацій з теми "Hemostasis":

1

Andrew, Marilee, and Lawrence Crum. An Acoustic Hemostasis Device for Advanced Trauma Care. Fort Belvoir, VA: Defense Technical Information Center, October 2001. http://dx.doi.org/10.21236/ada398720.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Crum, Lawrence, Marilee Andrew, Shahram Vaezy, Peter Kaczkowski, and Steven Kargl. An Acoustic Hemostasis Device for Acute Arterial Bleeding. Fort Belvoir, VA: Defense Technical Information Center, April 2004. http://dx.doi.org/10.21236/ada422316.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Carlson, Mark A., William H. Velander, Gustavo Larsen, Luis Nunez, and Wilson H. Burgess. Technologies for Hemostasis and Stabilization of the Acute Traumatic Wound. Fort Belvoir, VA: Defense Technical Information Center, October 2012. http://dx.doi.org/10.21236/ada602118.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Carlson, Mark A., William H. Velander, Gustavo Larsen, Luis Nunez, and Wilson H. Burgess. Technologies for Hemostasis and Stabilization of the Acute Traumatic Wound. Fort Belvoir, VA: Defense Technical Information Center, October 2013. http://dx.doi.org/10.21236/ada602120.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Zhigulina, K. V., and S. S. Spitsina. ASSESSMENT OF THE MAIN INDICATORS OF THE HEMOSTASIS SYSTEM IN PATIENTS WITH RHEUMATOID ARTHRITIS. DOI CODE, 2021. http://dx.doi.org/10.18411/wco-iof-esceo-2021-392.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Moore, II, and Bob M. Development of Hemostatic Agents. Fort Belvoir, VA: Defense Technical Information Center, August 2005. http://dx.doi.org/10.21236/ada454187.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Moore II, Bob M. Development of Hemostatic Agents. Fort Belvoir, VA: Defense Technical Information Center, January 2008. http://dx.doi.org/10.21236/ada476090.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Lewis, Terry W. Hemostatic Activity of Chitosan in Wound Management. Fort Belvoir, VA: Defense Technical Information Center, March 1989. http://dx.doi.org/10.21236/ada211370.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Snow, Carl, Cheryl Olson, and Ted Melcer. The Navy Medical Technology Watch: Hemostatic Dressing Products for the Battlefield. Fort Belvoir, VA: Defense Technical Information Center, September 2006. http://dx.doi.org/10.21236/ada477227.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Bode, Arthur P. Evaluation of Dried Storage of Platelets for Transfusion: Physiologic Integrity and Hemostatic Functionality. Fort Belvoir, VA: Defense Technical Information Center, June 1994. http://dx.doi.org/10.21236/ada280665.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

До бібліографії